Evidence map›Paper›PMID 38256252›Full record

ArticleInternational journal of molecular sciences2024

Performance of a Shotgun Prediction Model for Colorectal Cancer When Using 16S rRNA Sequencing Data.

Elies Ramon, Mireia Obón-Santacana, Olfat Khannous-Lleiffe, Ester Saus, Toni Gabaldón, Elisabet Guinó, David Bars-Cortina, Gemma Ibáñez-Sanz, Lorena Rodríguez-Alonso, Alfredo Mata and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Elies RamonColorectal Cancer Group, ONCOBELL Program, Institut de Recerca Biomedica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Mireia Obón-SantacanaColorectal Cancer Group, ONCOBELL Program, Institut de Recerca Biomedica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Olfat Khannous-LleiffeBarcelona Supercomputing Centre (BSC-CNS), 08034 Barcelona, Spain.
Ester SausBarcelona Supercomputing Centre (BSC-CNS), 08034 Barcelona, Spain.ORCID 0000-0002-2519-111X
Toni GabaldónBarcelona Supercomputing Centre (BSC-CNS), 08034 Barcelona, Spain.ORCID 0000-0003-0019-1735
Elisabet GuinóColorectal Cancer Group, ONCOBELL Program, Institut de Recerca Biomedica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
David Bars-CortinaColorectal Cancer Group, ONCOBELL Program, Institut de Recerca Biomedica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Gemma Ibáñez-SanzColorectal Cancer Group, ONCOBELL Program, Institut de Recerca Biomedica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.ORCID 0000-0001-6071-7343
Lorena Rodríguez-AlonsoGastroenterology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Alfredo MataDigestive System Service, Moisés Broggi Hospital, 08970 Sant Joan Despí, Spain.
Ana García-RodríguezEndoscopy Unit, Digestive System Service, Viladecans Hospital-IDIBELL, 08840 Viladecans, Spain.ORCID 0000-0001-7637-922X
Victor MorenoColorectal Cancer Group, ONCOBELL Program, Institut de Recerca Biomedica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.ORCID 0000-0002-2818-5487

Funding

Catalan Research Agency (AGAUR) SGR01551Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) action GenriskCOST action A18131 Ml4MicrobiomeEuropean Union's Horizon 2020 research and innovation programme ERC-2016-724173Fundació Marató TV3 875/C/2021Gordon and Betty Moore Foundation GBMF9742Instituto de Salud Carlos III IMPACT Grant IMP/00019 and CIBERINFEC CB21/13/00061- ISCIII-SGEFI/ERDFInstituto de Salud Carlos III PI17-00092 and PI20-01439Instituto de Salud Carlos III Sara Borrell CD21/00094"La Caixa" foundation LCF/PR/HR21/00737Spanish Association Against Cancer (AECC) Scientific Foundation GCTRA18022MORESpanish Ministerio de Universidades FPU2020-02907Spanish Ministry of Science and Innovation, cofounded by ERDF "A way of making Europe" PID2021-126067NB-I00, CPP2021-008552, PCI2022-135066-2 and PDC2022-133266-I00
6 · The paper itself

Abstract

Colorectal cancer (CRC), the third most common cancer globally, has shown links to disturbed gut microbiota. While significant efforts have been made to establish a microbial signature indicative of CRC using shotgun metagenomic sequencing, the challenge lies in validating this signature with 16S ribosomal RNA (16S) gene sequencing. The primary obstacle is reconciling the differing outputs of these two methodologies, which often lead to divergent statistical models and conclusions. In this study, we introduce an algorithm designed to bridge this gap by mapping shotgun-derived taxa to their 16S counterparts. This mapping enables us to assess the predictive performance of a shotgun-based microbiome signature using 16S data. Our results demonstrate a reduction in performance when applying the 16S-mapped taxa in the shotgun prediction model, though it retains statistical significance. This suggests that while an exact match between shotgun and 16S data may not yet be feasible, our approach provides a viable method for comparative analysis and validation in the context of CRC-associated microbiome research.

Indexed as

Colorectal NeoplasmsGastrointestinal MicrobiomeAlgorithmsHealth PersonnelHumansRNA, Ribosomal, 16SRNA, Ribosomal, 16S16Scolon cancergut microbiotametagenomicsmicrobial signaturepredictive modelshotgun

Identifiers

PMID38256252
PMCPMC10816515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.